These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Might a statin-oriented strategy be counterproductive in the treatment of diabetes mellitus? Mascitelli L; Pezzetta F; Goldstein MR Singapore Med J; 2008 Nov; 49(11):960-1. PubMed ID: 19037569 [No Abstract] [Full Text] [Related]
3. Hyperlipidaemia and cardiovascular disease: nonlipid-lowering effects of omega-3 fatty acids, statins and fibrates. Dominiczak M Curr Opin Lipidol; 2009 Feb; 20(1):79-81. PubMed ID: 19106712 [No Abstract] [Full Text] [Related]
4. Statin therapy in patients with type 2 diabetes. Lo V; Noviasky J; Nashelsky J Am Fam Physician; 2005 Sep; 72(5):866-8. PubMed ID: 16156346 [No Abstract] [Full Text] [Related]
5. Therapy and clinical trials: metabolic syndrome and cardiovascular risk management. Edavalath M; Rees A Curr Opin Lipidol; 2008 Aug; 19(4):438-9. PubMed ID: 18607195 [No Abstract] [Full Text] [Related]
6. Bibliography. Current world literature. Therapy and clinical trials. Curr Opin Lipidol; 2006 Dec; 17(6):667-90. PubMed ID: 17095912 [No Abstract] [Full Text] [Related]
7. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly]. MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640 [No Abstract] [Full Text] [Related]
8. Is it time to reconsider combination lipid therapy in high-risk diabetic patients? Blood AJ; Krasuski RA Curr Opin Lipidol; 2016 Jun; 27(3):310-1. PubMed ID: 27145105 [No Abstract] [Full Text] [Related]
9. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill? Wienbergen H; Senges J; Gitt AK Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489 [No Abstract] [Full Text] [Related]
10. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. Fletcher GF; Bufalino V; Costa F; Goldstein LB; Jones D; Smaha L; Smith SC; Stone N Am J Cardiol; 2007 Mar; 99(6C):1E-35E. PubMed ID: 17378996 [No Abstract] [Full Text] [Related]
11. [Preadmission use of statins as treatment for strokes]. González-Hernández A; López-Fernández JC; Fabre-Pi O; Cubero A Rev Neurol; 2007 Dec 1-15; 45(11):702-3. PubMed ID: 18050107 [No Abstract] [Full Text] [Related]
12. [Current knowledge about the effect of HMG-CoA reductase inhibitors]. Gesche M Dtsch Med Wochenschr; 1998 Jan; 123(5):135. PubMed ID: 9487300 [No Abstract] [Full Text] [Related]
14. Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)? Choudhury RP Curr Opin Lipidol; 2010 Apr; 21(2):161-2. PubMed ID: 20616630 [No Abstract] [Full Text] [Related]
15. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient. Ong HT QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501 [TBL] [Abstract][Full Text] [Related]
16. The HOPE study: comparison with other trials of secondary prevention. Otterstad JE; Sleight P Eur Heart J; 2001 Aug; 22(15):1307-10. PubMed ID: 11465962 [No Abstract] [Full Text] [Related]
17. From the editor. Brown WV J Clin Lipidol; 2011; 5(4):247-8. PubMed ID: 21784368 [No Abstract] [Full Text] [Related]
18. Pleiotropic effects of statins and beyond. Lansberg P Cardiology; 2009; 112(1):1-3. PubMed ID: 18577879 [No Abstract] [Full Text] [Related]
19. Are we lowering LDL cholesterol sufficiently? Barter P; Rye KA Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988 [No Abstract] [Full Text] [Related]